Sandoz has launched Wyost® (denosumab 120 mg) and Jubbonti® (denosumab 60 mg) across Europe, among the first denosumab biosimilars approved for all Xgeva® and Prolia® indications, targeting ...

SHANGHAI, Dec. 16, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with an integrated industry chain, announced that it has completed the first commercial shipment of ...

Zydus Lifesciences Ltd., an innovation-led healthcare company, with an international presence has launched ‘Zyrifa’, a denosumab biosimilar. Denosumab is a monoclonal antibody with several indications ...

Ashbringer is set to release their new record Subglacial on February 13 and we're thrilled to premiere the track "Vessels" for you all right now! I think I've listened to this song about 10 times this ...

Every cell in the body makes both RNA and peptides. But what emerges here is not just a story about molecules, but about trust The new pharmacy is a refrigerator. Not the kind that hums in a clinic, ...

The father of an Israeli woman abducted on October 7 has revealed his daughter was murdered in Gaza by a civilian doctor - and that he was later sent a video showing the moment she was killed. In the ...

Mumbai, Dec. 10 -- Denosumab is a monoclonal antibody with several indications related to bone health, primarily used in the treatment of osteoporosis and in preventing skeletal complications in ...

Across social media and encrypted messaging apps, a new frontier of weight loss is unfolding in real time, with people sourcing and injecting an experimental drug that regulators have not yet approved ...